FLT3

CAT # Igama lemveliso Inkcazo
CPDB0099 Quizartinib; AC-010220; AC-220 I-Quizartinib iyi-inhibitor ye-FMS ehlobene ne-tyrosine kinase 3 (FLT3; Kd = 1.6 nM) kwaye ibonisa ukukhetha okuphezulu kwe-FLT3 xa ivavanywa kwiphaneli ye-227 kinases eyongezelelweyo. Ivimbela ukwanda kwe-leukemia ye-cell line ye-MV4-11, egcina i-homozygous FLT3-ITD ukuguqulwa, kunye nexabiso le-IC50 le-0.56 nM.1 Kwi-1 mg / kg / ngosuku, i-quizartinib ibonakaliswe ukwandisa ukusinda kwimouse. imodeli ye-FLT3-ITD acute myeloid leukemia kunye nokuphelisa amathumba kwi Imodeli ye-xenograft ye-FLT3 exhomekeke kwi-mouse kwi-10 mg / kg.

Qhagamshelana nathi

Ukubuza

Iindaba zamva

  • Iindlela eziPhezulu ze-7 kuPhando lwezoPhando kwi-2018

    IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

    Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

  • I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

    I-ARS-1620: Isithinteli esitsha esithembisayo se-K...

    Ngokophononongo olupapashwe kwiSeli, abaphandi baye baphuhlisa inhibitor ethile ye-KRASG12C ebizwa ngokuba yi-ARS-1602 ebangele ukuhlehla kwethumba kwiimpuku. "Olu phononongo lubonelela ngobungqina bokuba i-KRAS eguqukayo inokuba...

  • I-AstraZeneca ifumana unyuso lolawulo lwamachiza e-oncology

    I-AstraZeneca ifumana unyuso lolawulo lwe...

    I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

Incoko ka-WhatsApp kwi-Intanethi!